SCHEMBL50679

SCHEMBL50679

CCCCCCC(F)C[O]

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.50
GPR84 Q9NQS5 5/20 0.41
FDPS P14324 3/20 0.41
FFAR1 O14842 1/20 0.41
CES2 O00748 1/20 0.41
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.40
THRB P10828 1/20 0.40
DNM1 Q05193 1/20 0.40
LCK P06239 1/20 0.40
PPARD Q03181 1/20 0.40
ZDHHC20 Q5W0Z9 1/20 0.40
ZDHHC2 Q9UIJ5 1/20 0.40
ADH1B P00325 1/20 0.39
ADH1C P00326 1/20 0.39
ADH1A P07327 1/20 0.39
ADH4 P08319 1/20 0.39
ADH7 P40394 1/20 0.39
LAP3 P28838 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL50664 1.00 MAPT (0.50) MAPTGPR84FDPSFFAR1CES2
SCHEMBL9688372 0.97
SCHEMBL601218 0.90
SCHEMBL8173118 0.84 MAPT (0.52) MAPTGPR84FDPSFFAR1CES2
SCHEMBL18725210 0.84 MAPT (0.52) MAPTGPR84FDPSFFAR1CES2
SCHEMBL24926247 0.84 MAPT (0.52) MAPTGPR84FDPSFFAR1CES2
SCHEMBL19853017 0.84 MAPT (0.52) MAPTGPR84FDPSFFAR1CES2
SCHEMBL10608053 0.84 MAPT (0.52) MAPTGPR84FDPSFFAR1CES2
SCHEMBL19026469 0.84 MAPT (0.52) MAPTGPR84FDPSFFAR1CES2
SCHEMBL16135675 0.84 MAPT (0.52) MAPTGPR84FDPSFFAR1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 999 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0260910-B1 3,6-DIPHENYLPYRIDAZINES Chisso Corporation (JP) 1992-05-27 EP claimed
US-12031079-B2 Polymerisable LC medium and polymer film with flat optical dispersion MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
CN-113039659-B Self-assembled monolayers for electrode modification and devices comprising such self-assembled monolayers 默克专利有限公司 2024-07-05 CN disclosed
EP-4015598-B1 LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME AND COMPOUNDS MERCK PATENT GMBH (DE) 2024-05-22 EP disclosed
EP-3704176-B1 ORGANIC SEMICONDUCTING COMPOUNDS RAYNERGY TEK INC (TW) 2024-05-15 EP disclosed
US-11958819-B2 Compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2024-04-16 US disclosed
CN-111247653-B Electrode for electronic device comprising organic semiconductor layer 弗莱克英纳宝技术有限公司 2024-04-09 CN disclosed
CN-113544186-B Organic semiconductor composition 天光材料科技股份有限公司 2024-03-19 CN disclosed
EP-3794650-B1 ORGANIC SEMICONDUCTORS RAYNERGY TEK INC (TW) 2024-03-13 EP disclosed
EP-3994234-B1 LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME AND COMPOUNDS MERCK PATENT GMBH (DE) 2024-02-21 EP disclosed
EP-0269963-B1 Ferroelectric liquid crystals HOFFMANN LA ROCHE (CH) 1995-02-22 EP disclosed
EP-0515972-A1 Polymerizable liquid crystal materials and polymer compositions displaying ferroelectric smectic liquid crystal phases MERCK PATENT GmbH (DE) 1992-12-02 EP disclosed
EP-0260910-B1 3,6-DIPHENYLPYRIDAZINES Chisso Corporation (JP) 1992-05-27 EP disclosed
US-5100577-A FERROELECTRIC LIQUID CRYSTAL MIXTURES AND COMPOUNDS AS WELL AS ELECTRO-OPTICAL DEVICES EMPLOYING SAME HOFFMAN-LA ROCHE INC. (US) 1992-03-31 US disclosed
CN-1035107-A FLUORINATED OLIGOPHENYL DERIVATIVES MERCK PATENT GMBH (DE) 1989-08-30 CN disclosed
US-4818429-A FERROELECTRIC LIQUID CRYSTAL DISPLAY ELEMENTS; GOOD RESPONSE CHISSO CORPORATION (JP) 1989-04-04 US disclosed
US-4818430-A LIQUID CRYSTALS CHISSO CORPORATION (JP) 1989-04-04 US disclosed
EP-0269963-A2 Ferroelectric liquid crystals F. HOFFMANN-LA ROCHE AG (CH) 1988-06-08 EP disclosed
EP-0260910-A1 3,6-Diphenylpyridazines Chisso Corporation (JP) 1988-03-23 EP disclosed
EP-0260153-A2 Cyclohexylphenylpyridazines Chisso Corporation (JP) 1988-03-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11958819-B2 Compounds for optically active devices PDE6C, ALDH1A2, PDE6A MAPT 490/4885GPR84 2230/4885FDPS 317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.